Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00527891|
Recruitment Status : Completed
First Posted : September 11, 2007
Last Update Posted : July 31, 2012
1. To compare the efficacy of 1.5T vs. 3T T1 and T2-weighted MR images sequences for the detection and evaluation of liver lesions.
|Condition or disease||Intervention/treatment|
|Liver Cancer||Procedure: Signa Excite 3.0 T MRI Scan|
Magnetic resonance imaging is taken with scanners at different magnetic field strength. The current practice at UTMDACC is to perform these exams at 1.5 Tesla. Tesla is the unit of strength of the magnetic field. This study will compare the images taken at the standard 1.5 Tesla (T) magnetic field with those at the newer 3.0T magnetic field.
You are already scheduled to receive a standard 1.5 T MR of the liver area as requested by your doctor. As part of this study, you will then be asked to return on a separate date to have a similar exam performed with the Signal 3.0T Excite MR scanner. You will return within a two week period from the date of your first MRI examination. The examination will be performed in a machine that looks similar to the 1.5T scanner. It will also take about the same amount of time as the examination at 1.5T.
The images taken by both scanners will be evaluated and compared. After you have had the second scan, your participation in this study will be over. If there are new findings identified with the new scan your doctor will be notified.
This is an investigational study. The 3.0T scan will be performed free of charge. A total of 20 patients will take part in this study All will be enrolled at UTMDACC.
This protocol is partially funded by a research grant from General Electric Medical Systems (GEMS).
|Study Type :||Observational|
|Actual Enrollment :||16 participants|
|Official Title:||Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions|
|Study Start Date :||June 2004|
|Actual Primary Completion Date :||September 2007|
Signa Excite 3.0 T MRI Scan
Signa Excite 3.0 T MRI Scan
Procedure: Signa Excite 3.0 T MRI Scan
Signa Excite 3.0 T MRI scan within a two week period from the date of receiving standard 1.5 T MR of the liver area.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00527891
|United States, Texas|
|U.T.M.D. Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Janio Szklaruk, MD||M.D. Anderson Cancer Center|